DSM invests in development of bio-based materials

– DSM Venturing, the corporate venturing unit of DSM, has participated in a $ 20 million financing round in Tianjin Green Bio-Science (TGBS). The proceeds will be used to build China’s largest manufacturing plant for Polyhydroxyalkanoates (PHA) in the Tianjin Economic Development Area (TEDA). The investment is in line with DSM’s ambitions to develop bio-based performance materials to meet customers’ growing needs for improved performance and environmental benefits at competitive costs. PHA offers, in response to the growing market need for eco-friendly solutions, a new biorenewable polymer platform for a broad range of applications from automotive to biomedical and electronics, including multiple forms like fibers, films and foams. In parallel with the venture investment, DSM and TGBS intend to work together to create new business in bio-based performance materials. This investment brings the total number of current company participations of DSM Venturing to 20. Venturing forms an integral part of DSM’s open innovation approach, focused on teaming up with innovative players all over the world.